| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BHVN | Biohaven Ltd. | Chief Executive Officer, Director | $44.7M | +$5M | +12.6% | Nov 13, 2025 |
| RPRX | Royalty Pharma plc | Director | $345K | May 13, 2025 | ||
| RVNC | Revance Therapeutics, Inc. | Director | $0 | Feb 4, 2025 | ||
| BHVN | Biohaven Pharmaceutical Holding Co Ltd. | Chief Executive Officer, Director | Oct 3, 2022 | |||
| AKLI | Akili, Inc. | Director | Jun 29, 2021 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|